The pharmaceutical business authorized the issuance of 92.85 lakh equity shares at an issue price of Rs 517 per share, which represents a 5% discount to the QIP floor price of Rs 544.02 per share. On March 26, the company closed its QIP.
Prashant Jain, a former veteran of HDFC Mutual Fund, oversaw 3P India Equity and Madhusudan Kela’s Cohesion MK. Institutions that received at least five percent of the QIP were recognized for having the best ideas.
Trending
- Reibus International has secured $30 million in funding
- YoLa Fresh Secures $7 Million in Funding Prior to Series A
- Iyris Secures Series A Funding of $16M
- Fintech company, InsightSoftware has acquired Fiplana
- Vegapay raises $5.5M in seed round
- Nigerian startup, Seamfix raises seed funding
- Denim, a freight factoring partner raises $63M
- HTX Ventures Provids Funding to Kelp DAO